Symptoms & Causes
Introduction
Fibrocartilaginous mesenchymoma is a rare tumor affecting bones, primarily in young patients. It is typically aggressive but does not metastasize. Surgical removal is often necessary due to its potential for local recurrence.
Reference: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 09 11]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33.
Related Terminology
Not recommended: fibrocartilaginous mesenchymoma with low-grade malignancy.
Subtype(s)
None
Symptoms
Fibrocartilaginous mesenchymoma can be asymptomatic or can present as a painful lesion with localized swelling.
Localization
Fibrocartilaginous mesenchymoma most frequently occurs in the metaphysis of long tubular bones (61%), followed by the iliac-pubic bones (18%), vertebrae (15%), and metatarsus and rib (3% each).
Epidemiology
Fibrocartilaginous mesenchymoma is very rare, with fewer than 40 reported cases. It tends to affect young patients (age range: 3 months to 27 years; median: 13 years), with a slight male predominance.
Etiology
Unknown